ZA953110B - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
ZA953110B
ZA953110B ZA953110A ZA953110A ZA953110B ZA 953110 B ZA953110 B ZA 953110B ZA 953110 A ZA953110 A ZA 953110A ZA 953110 A ZA953110 A ZA 953110A ZA 953110 B ZA953110 B ZA 953110B
Authority
ZA
South Africa
Prior art keywords
pharmaceuticals
Prior art date
Application number
ZA953110A
Other languages
English (en)
Inventor
John Robert Mansfield Dales
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA953110B publication Critical patent/ZA953110B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
ZA953110A 1994-04-19 1995-04-18 Pharmaceuticals ZA953110B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9407698A GB9407698D0 (en) 1994-04-19 1994-04-19 Pharmaceuticals

Publications (1)

Publication Number Publication Date
ZA953110B true ZA953110B (en) 1996-05-20

Family

ID=10753741

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA953110A ZA953110B (en) 1994-04-19 1995-04-18 Pharmaceuticals

Country Status (40)

Country Link
US (2) US6846927B1 (ko)
EP (1) EP0756597B1 (ko)
JP (1) JP3936734B2 (ko)
KR (1) KR100327147B1 (ko)
CN (1) CN1045963C (ko)
AP (2) AP582A (ko)
AT (1) ATE201209T1 (ko)
AU (1) AU691000B2 (ko)
BG (1) BG63464B1 (ko)
BR (1) BR9507494A (ko)
CA (1) CA2188181C (ko)
CZ (1) CZ287674B6 (ko)
DE (1) DE69520945T2 (ko)
DK (1) DK0756597T3 (ko)
DZ (1) DZ1872A1 (ko)
EG (1) EG20938A (ko)
ES (1) ES2158948T3 (ko)
FI (1) FI119691B (ko)
GB (1) GB9407698D0 (ko)
GR (1) GR3036338T3 (ko)
HK (1) HK1012348A1 (ko)
HU (1) HU226209B1 (ko)
IL (1) IL113409A (ko)
IN (1) IN183830B (ko)
MA (1) MA23518A1 (ko)
MX (1) MX9604942A (ko)
MY (1) MY128846A (ko)
NO (1) NO315000B1 (ko)
NZ (1) NZ287858A (ko)
OA (1) OA10376A (ko)
PL (1) PL181219B1 (ko)
PT (1) PT756597E (ko)
RO (1) RO118950B1 (ko)
RU (1) RU2158266C2 (ko)
SA (1) SA95150619B1 (ko)
SK (1) SK283193B6 (ko)
TW (1) TW311138B (ko)
UA (1) UA47401C2 (ko)
WO (1) WO1995028402A2 (ko)
ZA (1) ZA953110B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9615276D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9615253D0 (en) * 1996-07-20 1996-09-04 Smithkline Beecham Plc Pharmaceuticals
GB9807114D0 (en) * 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
GB9807116D0 (en) * 1998-04-02 1998-06-03 Smithkline Beecham Plc Novel process
EP1532151A2 (en) * 2002-08-26 2005-05-25 Teva Pharmaceutical Industries Limited Crystalline solid famciclovir forms i, ii, iii and preparation thereof
WO2004099208A1 (en) * 2003-04-30 2004-11-18 Teva Pharmaceutical Industries Ltd. Process for the preparation of famciclovir
EP1556383A1 (en) * 2003-09-04 2005-07-27 Teva Pharmaceutical Industries Ltd. Process for preparing famciclovir
US7458839B2 (en) * 2006-02-21 2008-12-02 Fci Americas Technology, Inc. Electrical connectors having power contacts with alignment and/or restraining features
US20050215787A1 (en) * 2004-03-26 2005-09-29 Joshi Ramesh A An improved process for the preparation of purines
EP1747223A1 (en) * 2004-05-18 2007-01-31 Teva Pharmaceutical Industries Ltd. Drying process for preparing crystalline solid famciclovir
GB2426247A (en) * 2005-05-20 2006-11-22 Arrow Int Ltd Methods of preparing purine derivatives such as famciclovir
CN102070636B (zh) * 2011-01-17 2012-05-23 浙江大学 喷昔洛韦的制备方法
CN104086552B (zh) * 2014-07-31 2016-01-13 济南兆康医药科技有限公司 一种喷昔洛韦的精制方法
CN104496991A (zh) * 2014-11-04 2015-04-08 常州康丽制药有限公司 高品质2-氨基-6-氯-9-(4-羟基-3–羟甲基丁基)嘌呤的制备方法
CN104744472A (zh) * 2015-03-12 2015-07-01 常州康丽制药有限公司 高品质2-氨基-6-氯-9-(4-羟基-3-羟甲基丁基)嘌呤的制备方法
CN108314685B (zh) * 2018-03-16 2020-08-25 上药康丽（常州）药业有限公司 一种2-氨基-6-氯-9-(4-乙酰氧基-3-乙酰氧甲基丁基)嘌呤的制备方法
CN110713490A (zh) * 2018-07-12 2020-01-21 浙江医药股份有限公司新昌制药厂 一种喷昔洛韦的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0302644B1 (en) * 1987-08-01 1997-01-29 Beecham Group Plc Purine compounds and their preparation
GB8817607D0 (en) * 1988-07-23 1988-09-01 Beecham Group Plc Novel process
GB8822236D0 (en) * 1988-09-21 1988-10-26 Beecham Group Plc Chemical process

Also Published As

Publication number Publication date
PT756597E (pt) 2001-11-30
BR9507494A (pt) 1997-08-12
AP9600870A0 (en) 1996-10-31
US6846927B1 (en) 2005-01-25
AU2670695A (en) 1995-11-10
CA2188181C (en) 2007-04-17
JPH09512000A (ja) 1997-12-02
SA95150619B1 (ar) 2005-05-04
DZ1872A1 (fr) 2002-02-17
HU226209B1 (en) 2008-06-30
CZ287674B6 (en) 2001-01-17
BG100926A (en) 1997-07-31
RO118950B1 (ro) 2004-01-30
UA47401C2 (uk) 2002-07-15
CZ305396A3 (en) 1997-06-11
NO315000B1 (no) 2003-06-23
SK283193B6 (sk) 2003-03-04
IN183830B (ko) 2000-04-29
KR970702280A (ko) 1997-05-13
EP0756597B1 (en) 2001-05-16
WO1995028402A2 (en) 1995-10-26
PL181219B1 (pl) 2001-06-29
IL113409A0 (en) 1995-07-31
AP9500730A0 (en) 1995-04-30
US7355043B2 (en) 2008-04-08
OA10376A (en) 2001-11-20
HUT75339A (en) 1997-05-28
SK133296A3 (en) 1997-05-07
CN1045963C (zh) 1999-10-27
FI964193A0 (fi) 1996-10-18
NZ287858A (en) 1998-06-26
AP582A (en) 1997-04-09
US20050101570A1 (en) 2005-05-12
JP3936734B2 (ja) 2007-06-27
AP703A (en) 1998-12-04
NO964395D0 (no) 1996-10-15
CN1150427A (zh) 1997-05-21
EG20938A (en) 2000-06-28
FI964193A (fi) 1996-12-18
EP0756597A1 (en) 1997-02-05
WO1995028402A3 (en) 1996-01-25
FI119691B (fi) 2009-02-13
DE69520945T2 (de) 2002-03-28
CA2188181A1 (en) 1995-10-26
DE69520945D1 (de) 2001-06-21
MA23518A1 (fr) 1995-12-31
IL113409A (en) 1999-08-17
HU9602891D0 (en) 1996-12-30
HK1012348A1 (en) 1999-07-30
NO964395L (no) 1996-10-15
PL316943A1 (en) 1997-02-17
AU691000B2 (en) 1998-05-07
TW311138B (ko) 1997-07-21
GB9407698D0 (en) 1994-06-15
BG63464B1 (bg) 2002-02-28
KR100327147B1 (ko) 2002-07-27
ATE201209T1 (de) 2001-06-15
DK0756597T3 (da) 2001-08-20
MX9604942A (es) 1998-05-31
MY128846A (en) 2007-02-28
GR3036338T3 (en) 2001-11-30
RU2158266C2 (ru) 2000-10-27
ES2158948T3 (es) 2001-09-16

Similar Documents

Publication Publication Date Title
AP9500730A0 (en) Pharmaceuticals
GB9601544D0 (en) Pharmaceuticals
ZA9510823B (en) Pharmaceuticals
EG23684A (en) Pharmaceuticals
GB9422781D0 (en) Pharmaceuticals
GB9606745D0 (en) Pharmaceuticals
GB9402230D0 (en) Pharmaceuticals
GB9411136D0 (en) Pharmaceuticals
ZA9510482B (en) Pharmaceuticals
GB9409686D0 (en) Pharmaceuticals
GB9426022D0 (en) Pharmaceuticals
GB9411304D0 (en) Pharmaceuticals
GB9411436D0 (en) Pharmaceuticals
GB9426018D0 (en) Pharmaceuticals
GB9403689D0 (en) Pharmaceuticals
GB9425012D0 (en) Pharmaceuticals
GB9423842D0 (en) Pharmaceuticals
GB9403688D0 (en) Pharmaceuticals
GB9423092D0 (en) Pharmaceuticals
GB9411437D0 (en) Pharmaceuticals
GB9423077D0 (en) Pharmaceuticals
GB9415653D0 (en) Pharmaceuticals
GB9413595D0 (en) Pharmaceuticals
GB9411438D0 (en) Pharmaceuticals
GB9610909D0 (en) Pharmaceuticals